Central Serous Chorioretinopathy Overview

Save information for later
Sign Up

Learn About Central Serous Chorioretinopathy

What is the definition of Central Serous Chorioretinopathy?
Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from the choroid (the blood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away.
What are the alternative names for Central Serous Chorioretinopathy?
  • Central serous chorioretinopathy
  • Central serous chorioretinopathy after bone marrow transplantation
  • Central serous choroidopathy
Who are the top Central Serous Chorioretinopathy Local Doctors?
Lawrence A. Yannuzzi
Elite in Central Serous Chorioretinopathy
Dr. Lawrence A. Yannuzzi
Ophthalmology
Elite in Central Serous Chorioretinopathy
Dr. Lawrence A. Yannuzzi
Ophthalmology

Vitreous Retina Macula Consultants Of New York

950 3rd Ave, 3rd floor, 
New York, NY 
212-861-9797
Languages Spoken:
English
See accepted insurances

Lawrence Yannuzzi is an Ophthalmologist in New York, New York. Dr. Yannuzzi is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Richard F. Spaide
Elite in Central Serous Chorioretinopathy
Dr. Richard F. Spaide
Ophthalmology
Elite in Central Serous Chorioretinopathy
Dr. Richard F. Spaide
Ophthalmology

Vitreous Retina Macula Consultants Of New York(Downtown)

110 Lafayette St, Suite 502, 
New York, NY 
212-234-3367
Languages Spoken:
English
See accepted insurances

Richard Spaide is an Ophthalmologist in New York, New York. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Giuseppe Querques
Elite in Central Serous Chorioretinopathy
Giuseppe Querques
Elite in Central Serous Chorioretinopathy
Giuseppe Querques

Centre Hospitalier Intercommunal Creteil University Paris Est

Creteil, FR 

Giuseppe Querques practices in Creteil, France. Mr. Querques is rated as an Elite expert by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

View All Doctors
What are the latest Central Serous Chorioretinopathy Clinical Trials?
Central Serous Chorioretinopathy and Micropulse Laser Treatment: Evaluation of Morphological and Functional Recovery
Central Serous Chorioretinopathy and Micropulse Laser Treatment: Evaluation of Morphological and Functional Recovery
Enrollment Status: Recruiting
Publish Date: September 23, 2025
Intervention Type: Other

Summary: To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

Match to trials
Find the right clinical trials for you in under a minute
Get started
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
Enrollment Status: Recruiting
Publish Date: July 30, 2024
Intervention Type: Dietary supplement
Study Phase: Not Applicable

Summary: To investigate the potential association between gut microbiota and central serous chorioretinopathy (CSC), we have observed in our clinical practice that CSC patients often experience chronic gastrointestinal issues. This observation has led us to hypothesize that CSC may be associated with gut dysbiosis. The Bifidobacterium genus is widely recognized as a beneficial gut bacterium, and numerous w...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center